Cargando…
CITED2 and the modulation of the hypoxic response in cancer
CITED2 (CBP/p300-interacting transactivator with Glu/Asp-rich C-terminal domain, 2) is a ubiquitously expressed protein exhibiting a high affinity for the CH1 domain of the transcriptional co-activators CBP/p300, for which it competes with hypoxia-inducible factors (HIFs). CITED2 is particularly eff...
Autores principales: | Fernandes, Mónica T, Calado, Sofia M, Mendes-Silva, Leonardo, Bragança, José |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360518/ https://www.ncbi.nlm.nih.gov/pubmed/32728529 http://dx.doi.org/10.5306/wjco.v11.i5.260 |
Ejemplares similares
-
Human Stem Cells for Cardiac Disease Modeling and Preclinical and Clinical Applications—Are We on the Road to Success?
por: Correia, Cátia D., et al.
Publicado: (2023) -
Exogenous WNT5A and WNT11 proteins rescue CITED2 dysfunction in mouse embryonic stem cells and zebrafish morphants
por: Santos, João M. A., et al.
Publicado: (2019) -
Functional Significance of SRJ Domain Mutations in CITED2
por: Chen, Chiann-mun, et al.
Publicado: (2012) -
A cell-autonomous role of Cited2 in controlling myocardial and coronary vascular development
por: MacDonald, Simon T., et al.
Publicado: (2013) -
Citrate lyase CitE in Mycobacterium tuberculosis contributes to mycobacterial survival under hypoxic conditions
por: Hu, Jialing, et al.
Publicado: (2020)